Effectiveness and safety of medium- and long-term elcatonin use in the prevention and treatment of bone mass loss

Christiansen, 1990, 12 1991, Consensus Development Conference. Prophylaxis and treatment of osteoporosis, Osteoporosis Int, 1, 114, 10.1007/BF01880454 Díez Pérez, 1989, Epidemiology of fractures of the proximal femur associated with osteoporosis in Barcelona, Spain, Calcif Tissue Int, 44, 382, 10.1007/BF02555965 Barth, 1988, Osteoporosis, Orthop Clin North Am, 19, 845, 10.1016/S0030-5898(20)31600-X Peck, 1988, Research directions in osteoporosis, Am J Med, 84, 275, 10.1016/0002-9343(88)90425-1 Díez Pérez, 1989, Aproximación a los costes de la fractura de cadera en España, Med Clin, 92, 721 Ross, 1990, A critical review of bone mass and the risk of fractures in osteoporosis, Calcif Tissue Int, 46, 149, 10.1007/BF02555036 Mazzuoli, 1986, Effects of salmon calcitonin in postmenopausal osteoporosis: A controlled double-blind clinical study, Calcif Tissue Int, 38, 3, 10.1007/BF02556587 Reginster, 1988, Is there any place for salmon calcitonin in prevention of postmenopausal bone loss?, Gynecol Endocrinol, 2, 195, 10.3109/09513599809029344 Gruber, 1984, Long-term calcitonin therapy in postmenopausal osteoporosis, Metabolism, 33, 295, 10.1016/0026-0495(84)90187-2 Wallach, 1977, Effects of salmon calcitonin on skeletal mass in osteoporosis, Curr Ther Res, 22, 556 Civitelli, 1988, Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment, J Clin Invest, 82, 1268, 10.1172/JCI113725 MacIntyre, 1988, Calcitonin for prevention of postmenopausal bone loss, Lancet, 1, 900, 10.1016/S0140-6736(88)91712-6 Yoshikawa, 1983, Effect of eel calcitonin derivative (elcatonin) in osteoporosis, J Jpn Orthop Assn, 57, 1717 Pietrogrande, 1990, Resultado del análisis densitométrico vertebral en la osteoporosis tratada con carbocalcitonina, Rev Clin Esp, 186, 24 1989, Italian Osteoporosis Network. Elcatonin in the treatment of osteoporosis. Results of a postmarketing surveillance study, Curr Ther Res, 45, 502 Nogarin, 1986, Multicentre trial of carbocalcitonin in disuse osteoporosis, Clin Trials J, 23, 87 Rico, 1992, Salmon calcitonin reduces vertebral rate in post-menopausal crush fracture syndrome, Bone Miner, 16, 131, 10.1016/0169-6009(92)90883-F Overgaard, 1992, Effect of calcitonin given intranasally on bone mass and fracture rates in established osteoporosis: A dose response study, BMJ, 305, 556, 10.1136/bmj.305.6853.556 Kanis, 1992, Evidence for efficacy of drugs affecting bone metabolism in preventing hip fracture, BMJ, 305, 1124, 10.1136/bmj.305.6862.1124 Gennari, 1985, Comparative effects on bone mineral content of calcium and calcium plus salmon calcitonin given in two different regimens in post-menopausal osteoporosis, Curr Ther Res, 38, 455 Rico, 1985, Resultados, a largo plazo, del tratamiento de la osteoporosis posmenopáusica con calcitonina y calcio, Med Clin, 84, 563 Morikawa, 1976, Synthesis of eel-calcitonin and (Asu 1,7) eel-calcitonin: Contribution of the disulfide bond to the hormonal activity, Experientia, 32, 1104, 10.1007/BF01927568 Martin, 1991, 131 Cantatore, 1988, Effetti della calcitonine sul metabolismo piastrinico, Ann Ital Med Interna, 3, 175 Huskisson, 1974, Measurement of pain, Lancet, 2, 1127, 10.1016/S0140-6736(74)90884-8 Del Río Barquero, 1988, Densitometría ósea por doble fotón. Aplicaciones clínicas, Rev Esp Med Nucl, 7, 54 Dunn, 1980, Measurement of bone mineral content in human vertebrae and hip by dual photon absorptiometry, Radiology, 136, 485, 10.1148/radiology.136.2.6773102 1987, Bone mineral densitometry, Ann Intern Med, 107, 217 Wahner, 1986, Methods and application of bone densitometry in clinical diagnosis, Crit Rev Clin Lab Sci, 24, 217, 10.3109/10408368609110274 Slemenda, 1988, Bone measurement: Which site to measure?, Am J Med, 84, 642, 10.1016/0002-9343(88)90098-8 Gluer, 1990, Comparative assessment of dual-photon absorptiometry and dual-energy radiography, Radiology, 175, 223, 10.1148/radiology.174.1.2294552 Johnston, 1991, Clinical use of bone densitometry, NEJM, 324, 1105, 10.1056/NEJM199104183241606 Nelson, 1991, Comparison of dual photon and dual energy X-ray bone densitometers in a clinic setting, Skeletal Radiol, 20, 591, 10.1007/BF01106090 Rencken, 1991, In vitro comparability of dual energy x-ray absorptiometry (DEXA) bone densitometers, Calcif Tissue Int, 48, 245, 10.1007/BF02556375 Trevisan, 1992, Bone mass measurement by DXA. Influence of analysis procedures and interunit variation, J Bone Miner Res, 7, 1373, 10.1002/jbmr.5650071204 Laskey, 1992, Comparison of the effect of different reference data on Lunar DPX and Hologic QDR-1000 dual-energy x-ray absorptiometers, Br J Radiol, 65, 1124, 10.1259/0007-1285-65-780-1124 Orwoll, 1993, Precision of dual-energy x-ray absorptiometry. Development of quality control rules and their application in longitudinal studies, J Bone Miner Res, 8, 693, 10.1002/jbmr.5650080607 Valkema, 1990, Limited precision of lumbar spine dual-photon absorptiometry by variations in the soft-tissue background, J Nucl Med, 31, 1774 Mazess, 1991, Calibration of dual-energy x-ray absorptiometry for bone density, J Bone Miner Res, 6, 799, 10.1002/jbmr.5650060804 Fischer, 1993, Phantom studies in osteoporosis, Eur J Nucl Med, 20, 434, 10.1007/BF00209004 Reid, 1991, The influence of osteophytes and aortic calcification on spinal mineral density in postmenopausal women, J Clin Endocrinol Metab, 72, 1372, 10.1210/jcem-72-6-1372 Masud, 1993, Effect of spinal osteophytosis on bone mineral density measurements in vertebral osteoporosis, BMJ, 307, 172, 10.1136/bmj.307.6897.172 Morita, 1993, Some problems of dual-energy x-ray absorptiometry in the clinical use, Osteoporosis Int, 3, S87, 10.1007/BF01621874 Leidig, 1990, A study of complaints and their relation to vertebral destruction in patients with osteoporosis, Bone Miner, 8, 217, 10.1016/0169-6009(90)90107-Q Cook, 1993, Quality of life issues in women with vertebral fractures due to osteoporosis, Arthritis Rheum, 36, 750, 10.1002/art.1780360603 Gennari, 1991, Use of calcitonin in the treatment of bone pain associated with osteoporosis, Calcif Tissue Int, 49, S9, 10.1007/BF02561370 Guidobono, 1985, Role of catecholamines in calcitonin-induced analgesia, Pharmacology, 31, 342, 10.1159/000138143 Mitsuma, 1988, Effects of eel calcitonin on plasma beta-endorphin-like immunoreactivity levels in rats, Endocrinol Exp, 22, 107 Pun, 1989, Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporosis vertebral fractures, Clin Ther, 11, 205 Ljunghall, 1991, Synthetic human calcitonin in postmenopausal osteoporosis: A placebo-controlled, double-blind study, Calcif Tissue Int, 49, 17, 10.1007/BF02555897 Lyritis, 1991, Analgesic effect of salmon calcitonin in osteoporotic vertebral fractures: A double-blind placebo-controlled clinical study, Calcif Tissue Int, 49, 369, 10.1007/BF02555844 Saito, 1981, Clinical effect of synthetic eel calcitonin (elcatonin) on lumbodorsal pain in association with osteoporosis, Med Consult New Remedies, 18, 144 Jaeger, 1992, Calcitonin in phantom limb pain: A double-blind study, Pain, 48, 21, 10.1016/0304-3959(92)90127-W Schiraldi, 1985, Analgesic activity of high doses of salmon calcitonin in lung cancer, Curr Ther Res, 38, 592 Gennari, 1988, Calcitonin and pain management, Curr Ther Res, 44, 712 1994, Screening. Assessment of fracture risk and its applications to screening for postmenopausal osteoporosis, WHO Technical Report Series, 843, 78 Johnston, 1991, Clinical use of bone densitometry, NEJM, 324, 1105, 10.1056/NEJM199104183241606 Ross, 1987, Definition of a spine fracture threshold based upon prospective fracture risk, Bone, 8, 271, 10.1016/8756-3282(87)90001-9 Pedetti, 1993, Are diphosphonates a valid alternative to estrogen in the prevention of post-menopausal osteoporosis? Cohn, 1971, Effects of porcine calcitonin on calcium metabolism in osteoporosis, J Clin Endocrinol, 33, 719, 10.1210/jcem-33-5-719 Overgaard, 1990, Discontinuous calcitonin treatment of established osteoporosis. Effects of withdrawal of treatment, Am J Med, 89, 1, 10.1016/0002-9343(90)90089-V Overgaard, 1991, Long-term treatment of established osteoporosis with intranasal calcitonin, Calcif Tissue Int, 49, S60, 10.1007/BF02555091 Rozenberg, 1993, Decrease of bone mineral density during estrogen substitution therapy, Maturitas, 17, 205, 10.1016/0378-5122(93)90048-M Avioli, 1991, Heterogenicity of osteoporosis syndromes and the response to calcitonin therapy, Calcif Tissue Int, 49, S16, 10.1007/BF02561372 Riggs, 1983, Heterogenicity of involutional osteoporosis: Evidence for two osteoporosis syndromes, Am J Med, 75, 899, 10.1016/0002-9343(83)90860-4 Avioli, 1988, Rationale for the use of calcitonin in postmenopausal osteoporosis, Ann Chir Gynaecol, 77, 224 Johnston, 1985, Heterogeneity of fracture syndromes in postmenopausal women, J Clin Endocrinol Metab, 53, 551, 10.1210/jcem-61-3-551 Avioli, 1992, Osteoporosis syndromes: Patient selection for calcitonin therapy, Geriatrics, 47, 58 Luisetto, 1990, Formation of antibodies to Asu-eel-calcitonin during cyclic treatment for postmenopausal osteoporosis, Curr Ther Res, 48, 320 Reginster, 1990, Influence of specific-anti-salmon calcitonin antibodies on biological effectiveness of nasal salmon calcitonin in Paget's disease of bone, Scand J Rheumatol, 19, 83, 10.3109/03009749009092626 Rico, 1982, Nuestra experiencia en el tratamiento de la osteoporosis postmenopáusica, Med Clin, 78, 322 Zorzin, 1984, Postmenopausal osteoporosis: Therapeutic and side effects of different calcitonins, Curr Ther Res, 36, 473 Wimalawansa, 1993, Long- and short-term side effects and safety of calcitonin in man: A prospective study, Calcif Tissue Int, 52, 90, 10.1007/BF00308314 Gennari, 1983, Gli effetti collaterali di differenti clacitonine, 93